MedTrace Logo

Apolipoprotein A-I Gene Polymorphism and Atherosclerosis

NCT00005183 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2017-12-21

No results posted yet for this study

Summary

To further define the linkage of the Apo A-I gene polymorphism to genetic high density lipoprotein (HDL) deficiency and premature coronary artery disease. Also, to utilize this gene marker to define the prevalence of genetic HDL deficiency in patients with premature coronary disease and to determine the relative risk of premature coronary disease associated with the Apo A-I gene polymorphism.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Tufts University

    lead OTHER

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1985-12-31
Completion
1988-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005183 on ClinicalTrials.gov